// App-Quantinova.ai

: Upregulation of Tissue Factor May Contribute to Thrombosis in Polycythemia Vera and Essential Thrombocythemia

Researchers

Presenter

  • Brandi Reeves

Principal Investigators

  • Soo Jin Kim

  • Jihyun Song

  • Radhika Gangaraju

  • Rafal Pawlinski

  • Perumal Thiagarajan

  • Victor R. Gordeuk

  • Nigel S. Key

  • Josef T. Prchal

Medical Centers

  • Hematology / Oncology, Univeristy of North Carolina, Chapel Hill, NC

  • Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

  • Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL

  • Baylor College of Medicine, Houston, TX

  • University of Illinois at Chicago, College of Medicine, Rockford, IL.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Essential thrombocythemia

  • Polycythemia vera

  • Venous thrombosis

Biomarkers

  • Coagulation Factor III, Tissue Factor

  • P-selectin

  • Glucose transporter 1

  • Hypoxia-inducible factor-1

  • Serpin E1

  • Thrombospondin-1

Drug/Treatment

  • Interleukin

  • Digoxin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved